Marissa Natelson Love

Marissa Natelson Love
Associate Professor

Positions

Principal Investigator On

Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease awarded by University of Southern California 2019 - 2024

The A3 Study: Ante-Amyloid Prevention of Alzheimer's Disease awarded by University of Southern California 2019 - 2023

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension Study awarded by University of Southern California 2019 - 2020

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease(A4 Study) awarded by University of Southern California 2016 - 2020

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study A Companion Observational Study to Antl-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial awarded by University of Southern California 2016 - 2020

Alzheimer's Disease Cooperative Study - A4 Study awarded by University of Southern California 2017 - 2020

Clinical Correlates of Family Quality of Life in Dementia awarded by ALZHEIMER'S OF CENTRAL ALABAMA 2015 - 2017

Investigator On

UAB Alzheimer's Disease Research Center awarded by National Institute on Aging/NIH/DHHS 2020 - 2023

Private Grant awarded by Genentech 2018 - 2022

Private Grant awarded by BIOGEN MA INC 2018 - 2022

A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multicenter Study of Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease (“Protocol”). awarded by Washington University 2018 - 2022

Private Grant awarded by BIOGEN MA INC 2014 - 2021

Private Grant awarded by EISAI, INC. 2013 - 2021

Improving Family Quality of Life Through Training to Reduce Care-Resistant Behaviors by People with Alzheimer Dementia and Traumatic Brain Injury awarded by DOD - ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY 2016 - 2021

Global Alzheimer’s Platform Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease awarded by University of Southern California 2019 - 2021

A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease awarded by Washington University 2013 - 2020

Private Grant awarded by BIOGEN, INC. 2018 - 2020

Private Grant awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2020

Private Grant awarded by ABBVIE INC 2018 - 2020

Private Grant awarded by ABBVIE INC 2017 - 2020

McKnight Brain Aging Registry awarded by University of Miami 2016 - 2020

Private Grant awarded by BIOGEN IDEC, INC. 2017 - 2020

Private Grant awarded by BIOGEN, INC. 2016 - 2019

Private Grant awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2015 - 2019

Private Grant awarded by NEURIM PHARMACEUTICALS 2017 - 2019

The Frontotemporal Lobar Degeneration Clinical Research Consortium awarded by University of California, San Francisco 2016 - 2019

Private Grant awarded by H. LUNDBECK A/S 2014 - 2019

Private Grant awarded by AXOVANT SCIENCES, INC. - NEW 2017 - 2019

Private Grant awarded by JANSSEN RESEARCH & DEVELOPMENT, LLC 2017 - 2018

Private Grant awarded by AXOVANT SCIENCES, INC. - NEW 2016 - 2018

Causes, Treatment, and Prevention of Corticobasal Degeneration awarded by University of California, San Francisco 2014 - 2018

Private Grant awarded by AVID RADIOPHARMACEUTICALS 2014 - 2018

Private Grant awarded by H. LUNDBECK A/S 2014 - 2018

Private Grant awarded by ASSUREX HEALTH INC. 2016 - 2018

Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) Study: A Coverage with Evidence Development Longitudinal Cohort Study awarded by American College of Radiology 2016 - 2018

Private Grant awarded by AVANIR PHARMACEUTICALS, INC. 2016 - 2018

Tau PET Imaging for the USC Alzheimer's Therapeutic Research Institute (USC ATRI) A4 Trial (“A4 TAU”) awarded by University of Southern California 2017

Advancing Research and Treatment for Frontotemporal Lobar Degeneration [ARTFL]: Research Project 1 & 2 awarded by University of California, San Francisco 2015 - 2017

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study) awarded by University of Southern California 2016 - 2017

Alzheimer's Disease Cooperative Study - A4 Study awarded by University of Southern California 2015 - 2017

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study: A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial awarded by University of Southern California 2015 - 2016

Private Grant awarded by C2N DIAGNOSTICS, LLC 2015 - 2016

Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2) awarded by University of Southern California 2015 - 2016

Alzehimer's Disease Neuroimaging Initiative (ADNI) awarded by University of California, San Diego 2005 - 2016

Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4 Study) awarded by University of California, San Diego 2012 - 2016

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - The LEARN Study A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial awarded by University of California, San Diego 2015

Private Grant awarded by TRANSITION THERAPEUTICS INC. 2013 - 2015

Alzheimer's Disease Cooperative Study awarded by University of California, San Diego 2013 - 2015

A Double-Blind, Placebo-Controlled (Sham Surgery), Randomized, Multicenter Study Evaluating CERE-110 Gene Delivery in Subjects with Mild to Moderate Alzheimer's Disease (CERE 110-3) awarded by University of California, San Diego 2011 - 2013

Amyloid Imaging, VMCI, and Analysis for ADNI awarded by University of California, San Diego 2009 - 2012

Background

Education And Training

Doctor of Medicine, Emory University 2009

UAB Hospital, Internship 2010

UAB Hospital, Residency 2013

UAB SOM, Postdoctoral Fellowship 2015